Summary
This paper discusses the potential of light therapy as a treatment for depression, and the design of a randomised controlled trial to test its effectiveness in primary care.
Categories
Depression: The paper explores the use of light therapy as a treatment for depression, including its effectiveness and safety, and designs a trial to test its use in primary care.
Phototherapy: The paper discusses the use of light therapy, a form of phototherapy, as a potential treatment for depression.
Mood regulation: The paper investigates the potential of light therapy to regulate mood in the treatment of depression.
Author(s)
J Walsh
Publication Year
2018
Related Publications
Depression
- The twoāprocess model of sleep regulation: a reappraisal
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Nocturnal light exposure impairs affective responses in a wavelength-dependent manner
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Shortāwavelength enrichment of polychromatic light enhances human melatonin suppression potency
Mood regulation
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Nocturnal light exposure impairs affective responses in a wavelength-dependent manner
- The role of the circadian clock in animal models of mood disorders.
- Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells
- Early electronic screen exposure and autistic-like symptoms